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ABSTRACT
Zinc-finger nucleases (ZFNs) and TAL effector nu-
cleases (TALENs) have been shown to induce
targeted mutations, but they have not been exten-
sively tested in any animal model. Here, we describe
a large-scale comparison of ZFN and TALEN
mutagenicity in zebrafish. Using deep sequencing,
we found that TALENs are significantly more likely
to be mutagenic and induce an average of 10-fold
more mutations than ZFNs. We observed a strong
correlation between somatic and germ-line mutag-
enicity, and identified germ line mutations using
ZFNs whose somatic mutations rates are well
below the commonly used threshold of 1%. Guide-
lines that have previously been proposed to predict
optimal ZFN and TALEN target sites did not predict
mutagenicity in vivo. However, we observed a sig-
nificant negative correlation between TALENmutag-
enicity and the number of CpG repeats in TALEN
target sites, suggesting that target site methylation
may explain the poor mutagenicity of some TALENs
in vivo. The higher mutation rates and ability to
target essentially any sequence make TALENs the
superior technology for targeted mutagenesis in
zebrafish, and likely other animal models.
INTRODUCTION
Zinc-ﬁnger nucleases (ZFNs) and TAL effector nucleases
(TALENs) have recently emerged as powerful tools for
generating targeted genomic mutations. These proteins
bind speciﬁc DNA sequences and induce double-strand
DNA breaks that are repaired by non-homologous end
joining (1), an error-prone process that often results in
insertion or deletion (indel) mutations. ZFNs have been
studied for several years, but their widespread use has been
limited by the difﬁculty of targeting them to speciﬁc DNA
sequences. Selection assays for identifying zinc ﬁngers that
bind speciﬁc targets are laborious and challenging for
non-specialist laboratories (2,3). An alternative method,
known as modular assembly, combines pre-selected zinc-
ﬁnger modules into arrays (1). These ZFNs are relatively
easy to generate but have low success rates (4), although
signiﬁcant progress has recently been made (5,6).
Proprietary methods have also been used to generate
ZFNs that are effective in zebraﬁsh (7), but these nucleases
must be purchased and are expensive. Another approach,
context-dependent assembly (CoDA) (8), does not require
selection assays and was claimed to have a success rate
comparable with selection-based methods. However, the
sequences that can be targeted using CoDA are limited
(8) and, as for all ZFN technologies, there is no established
code for speciﬁc zinc ﬁnger/DNA interactions. In contrast,
TALENs contain a variable number of repeated modules
that each preferentially binds a speciﬁc nucleotide.
Therefore, TALENs can in principle be targeted to any
DNA sequence without the need for selection assays.
Furthermore, TALENs can be constructed using
standard molecular biology techniques (9). Both ZFNs
and TALENs can induce mutations in zebraﬁsh (3,5–15),
but these approaches have not been extensively tested and
compared for mutagenicity in any animal model. Here, we
describe a large-scale analysis and comparison of ZFN and
TALEN mutagenicity in developing zebraﬁsh embryos.
MATERIALS AND METHODS
Animal care
All experiments were performed by mating TL and AB
wild-type zebraﬁsh strains using standard protocols (16)
in accordance with the California Institute of Technology
Institutional Animal Care and Use Committee guidelines.
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Construction of ZFNs and TALENs
ZFNs and TALENs were designed using the ZiFIT
Targeter (http://ziﬁt.partners.org/ZiFiT) (9,17). DNA
fragments encoding zinc-ﬁnger arrays were synthesized
(Epoch Life Science Inc.) and cloned into FokI EL/KK
(18) heterodimeric expression vectors by BamHI/XbaI
(pMLM290 and pMLM292) or NotI/XbaI (pMLM800
and pMLM802) digestion (19). Each ZFN contained
three zinc ﬁngers. TALE repeat arrays were constructed
using the REAL Assembly TALEN Kit (9) and were
cloned into the wild-type FokI expression vectors
JDS70, JDS71, JDS74 and JDS78. All TALENs were
sequence veriﬁed before mRNA synthesis. Plasmids were
obtained from the non-proﬁt plasmid repository Addgene.
RNA transcription and injection
ZFN and TALEN expression plasmids were linearized
with PmeI and puriﬁed using the polymerase chain
reaction (PCR) Puriﬁcation Kit (Qiagen). mRNA was
synthesized using 500 ng of puriﬁed linear DNA as
template and the mMessage mMachine T7 Ultra kit
(Ambion). The transcription reaction yielded 20 mg of
polyA tailed mRNA, which was dissolved in 20 ml of
nuclease-free water. mRNA synthesis and polyA tailing
were veriﬁed by agarose gel electrophoresis. Final
mRNA concentrations ranged from 0.8 to 1.2 mg/ml.
Approximately 50–100 pg of each ZFN or TALEN
mRNA was injected into the cell of zebraﬁsh embryos at
the one-cell stage. mRNA concentrations that were sufﬁ-
cient to cause developmental defects in 10–50% of injected
embryos were used to assay for somatic mutations and to
generate germ line mutants.
Analysis of somatic mutations
For each ZFN and TALEN, genomic DNA was prepared
from 12 injected embryos at 72 h post-fertilization (h.p.f.)
as previously described (19). Embryos were incubated in
500ml of sodium dodecyl sulfate lysis buffer [10 mM of
Tris pH 8.0, 200mM of NaCl, 10mM of ethylenediami-
netetraacetic acid (EDTA), 0.5% of sodium dodecyl
sulfate, 100 mg/ml of proteinase K] overnight at 50C
with occasional gentle mixing until no clumps were
visible. Genomic DNA was then puriﬁed by phenol/
chloroform extraction and dissolved in 40 ml of TE
(10mM of Tris pH 8.0, 0.5mM of EDTA). Targeted
genomic regions were ampliﬁed using Amplitaq
(Invitrogen), with amplicons ranging in size from 175 to
350 bp. Because of the short Illumina sequence read
length, for each PCR reaction, one primer was designed
to anneal 6–12 bp away from the spacer. PCR products
were puriﬁed using the PCR Puriﬁcation Kit (Qiagen) and
pooled at roughly equal molar ratios. Sequencing libraries
were prepared by following the Illumina TruSeq Genomic
DNA protocol without the DNA fragmentation step. The
pooled PCR products were end repaired, A-tailed and
ligated to TruSeq single-index adaptors. The adaptor-
ligated DNA was gel puriﬁed and PCR ampliﬁed to
produce ﬁnished libraries. The libraries were sequenced
using an Illumina GAIIx machine in the single read
38-nt mode, producing 34.1 million reads, and using an
Illumina HiSeq2000 machine in the single-read 50-nt
mode, producing 144.1 million reads.
Detecting indels using short-read data is challenging
because the commonly used alignment algorithms de-
veloped for high-throughput sequencing data, such as
bowtie (20) and ELAND, cannot map discontinuous
reads. Aligners that use the split-read method, which
maps deﬁned portions of the read separately before
creating the ﬁnal alignment, such as tophat (21) and
ELAND2, suffer from poor sensitivity of indel detection
because of the requirement for the indel site to fall
between the mapped portions of the read. Custom imple-
mentations of the split-read method suffer from similar
sensitivity problems. Also, many split-read aligners,
including tophat, were designed for the alignment of
RNA-Seq data and are much more sensitive in aligning
discontinuous reads that span splice junctions, which is
not the case for our data.
To detect indels rigorously, we used a combination of
two methods. We ﬁrst aligned reads to target genomic
regions using the SHRiMP2 software package (22,23),
which allowed us to identify small indels with high sensi-
tivity. SHRiMP2 uses the vectorized Smith–Waterman al-
gorithm for local alignment during the candidate mapping
location identiﬁcation phase, followed by the full Smith–
Waterman alignment to detect single-nucleotide poly-
morphisms and indels. It has been shown to have the
highest sensitivity of the currently available short-read
aligners (22,23). Despite its high sensitivity for small
indels, SHRiMP2 is unable to map reads across large in-
sertions or deletions. To identify such events in our data,
we mapped reads that failed to align with SHRiMP2 using
BLAT, which is capable of ﬁnding regions of high simi-
larity separated by large gaps (24). Mappings produced by
SHRiMP2 were output in the SAM format, whereas the
BLAT-native psl format was converted to SAM using the
psl2sam.pl script provided by the samtools package (25).
The SAM format-deﬁned CIGAR representation of the
alignment for each read was then used to identify inser-
tions and deletions using a custom perl script (available on
request). We then removed indels that were closer than
17 nt, the length of the shortest PCR primer, to the 50-
end of the read, or did not have at least a 5-nt continuous
match on the 30-end, which may correspond to incorrect
alignments. We also ﬁltered out 1-nt indels, which may
result from PCR or sequencing errors. The ﬁltered indels
produced by SHRiMP and BLAT were merged to produce
the ﬁnal indel list.
Isolation of germ line mutants
Zebraﬁsh embryos injected with a ZFN or TALEN pair
were raised to adulthood and mated to other potential
founders or wild-type ﬁsh. Depending on the somatic
mutation rate, genomic DNA was isolated from a pool
of 1–6 embryos at 72 h.p.f., with up to 96 embryos
tested for each ﬁsh. Embryos were incubated in embryo
lysis buffer (10mM of Tris–HCl pH 7.5, 1mM of EDTA,
50mM of KCl, 0.3% of Tween 20, 0.3% of NP40) for
10min at 98C. Proteinase K was then added to a ﬁnal
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concentration of 1mg/ml, and the lysis reaction was
incubated overnight at 55C, followed by 10 min at
98C. One microliter of this solution was used as
template for PCR.
Targeted genomic regions were ampliﬁed using
Amplitaq (Invitrogen) with amplicons ranging in size
from 200 to 550 bp. In cases where an indel was
expected to delete a restriction enzyme site, half of the
PCR reaction was digested with the appropriate restric-
tion enzyme and analysed by agarose gel electrophoresis.
In cases where the targeted region did not overlap with a
restriction enzyme site, PCR was performed using a
standard forward primer and a reverse primer
ﬂuorescently labelled with 6-FAM, HEX (Integrated
DNA Technologies) or NED (Applied Biosystems). For
PCR using ﬂuorescently labelled primers, we performed a
ﬁnal 1-h incubation at 60C to ensure that an extra ad-
enosine was added to the 30-end of all PCR products.
Fluorescent PCR products were run on an ABI 3730
DNA analyzer (Applied Biosystems), and PCR product
sizes were analysed using Peak Scanner (Applied
Biosystems). To conﬁrm indel sequences, genomic DNA
from single embryos was ampliﬁed and sub-cloned using
the Strataclone PCR Cloning Kit (Stratagene), and DNA
from several independent colonies was sequenced. DNA
sequences were analysed using SeqBuilder and SeqMan
(DNAStar Lasergene).
Statistical methods
Mutation rate and size data do not follow a normal dis-
tribution; therefore, we used non-parametric methods to
analyse these data. The non-parametric Wilcoxon
rank-sum test (also known as Mann–Whitney U-test or
Mann–Whitney–Wilcoxon test) was used to examine stat-
istically signiﬁcant differences in measurement variables
(mutation rate or size) between two nominal variables
(ZFN versus TALEN). Correlations were used to test
whether pairs of variables co-vary. Pearson’s linear correl-
ation was used to test interval data, whereas Spearman’s
rank correlation was used to test ordinal data. Results of
the correlations are reported as the r2-value (coefﬁcient of
determination) and P-value. Data are displayed as scatter
or box plots, and signiﬁcant linear correlations were add-
itionally displayed with a regression line. All tests were
two-tailed, and alpha level was P< 0.05.
RESULTS
Few CoDA ZFNs induce somatic mutations in vivo
In a previous study, 12 of 24 (50%) CoDA ZFNs induced
somatic mutations in zebraﬁsh, with indel rates between 1
and 17% (8). However, these ZFNs were pre-screened for
activity using a bacterial reporter assay. Because only
75% of CoDA zinc ﬁngers were found to be active in
the reporter assay (8), the success rate of CoDA ZFN
pairs that are not pre-screened was estimated at 28%
(50% 75% left ZFN 75% right ZFN). Another
study found that 3 of 17 (18%) CoDA ZFNs that were
not pre-screened induced somatic mutations in zebraﬁsh,
with indel rates of 1–3% (11). To more comprehensively
evaluate CoDA ZFN mutagenicity in vivo, we generated
84 ZFN pairs targeting 66 zebraﬁsh genes. We screened
for indels using deep sequencing, generating an average of
1 200 000 reads per target. In contrast, most studies have
analysed 96 sequence reads; hence, ZFNs that induced
indels at rates <1% would likely not have been identiﬁed
as mutagenic.
Of the 84 ZFN pairs tested, 21 (25%) induced indels in
>1% of sequence reads, in close agreement with the pre-
dicted rate of 28% (8,11), and only 5 (6%) produced indel
rates >10% (Figure 1c, Supplementary Figure S1 and
Supplementary Table S1). Thus, CoDA ZFNs have rela-
tively low success rates and few CoDA ZFNs induce mu-
tations at high rates. A genomic region that was not
targeted by a ZFN gave an indel rate of 0.009% (Supple-
mentary Table S1), indicating a false-positive rate of
0.01%. Surprisingly, many ZFNs induced indels at low
frequencies (Figure 1c, Supplementary Figure S1 and
Supplementary Table S1). Fifty-four ZFNs (64%)
induced indels at rates between the negative control
value of 0.01% and 1%, and 18 (21%) induced indels at
rates between 0.1% and 1%. Only nine (11%) produced
indels at frequencies below the negative control. Thus,
most CoDA ZFNs are mutagenic in vivo but induce mu-
tations at frequencies below the commonly used threshold
of 1%. A caveat to using Illumina-based deep sequencing
for indel detection is that one primer must be located close
to the targeted region because of the short-sequence read
length. Therefore, deletions removing more than 9 bp
beyond the spacer on one side of the targeted region will
not be detected. Indeed, of the 20 ZFN-induced germ line
mutations in 8 genes that we conﬁrmed using Sanger
sequencing (see below), 2 would not have been detected
using deep sequencing, suggesting that our methodology
may underestimate indel rates by 10%, although the
sample size is modest. An additional caveat is that our
requirement that both the 50-and 30-ends of a sequence
read align to its reference sequence (see ‘Materials and
Methods’ section) will result in a failure to detect large
insertions. However, none of the 91 germ line mutations
that we identiﬁed (see below) contain insertions that are
too large to align to their reference sequence using our
approach, suggesting that this is unlikely to signiﬁcantly
affect quantiﬁcation of somatic mutation rates.
Germ line mutations can be generated using ZFNs that
have low somatic indel rates
To determine the relationship between somatic and germ
line mutation rates, we isolated germ line mutants using
ZFNs that induced somatic mutations at a range of
frequencies. We observed a strong correlation between
somatic and germ line mutation rates (Figure 2,
r2=0.92, P=1.8 104 for eight ZFN pairs).
Surprisingly, ZFNs with somatic indel rates as low as
0.27% and 0.33% produced germ line mutations in 8%
(3/38) and 7% (3/42) of ﬁsh, respectively. Thus, ZFNs
whose somatic indel rates are well below the commonly
used threshold of 1% can be used to isolate germ line
mutants at reasonable frequencies. As a result, it should
be possible to isolate germ line mutations using at least
Nucleic Acids Research, 2013, Vol. 41, No. 4 2771
 at California Institute of Technology on M
ay 30, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Figure 1. TALENs induce somatic indels at higher rates than ZFNs in zebraﬁsh embryos. Average somatic indel rates are shown for all 84 ZFN and
34 TALEN pairs tested (a) and for the 33 ZFN and 33 TALEN active pairs (b). Nucleases that induce somatic indels at rates >0.27% are deﬁned as
active, because this rate is sufﬁcient to generate germ line mutations. The difference in mutation rates for ZFNs and TALENs is statistically
signiﬁcant, indicated by asterisks, with P=5.1 1012 for all nucleases (a) and P=6.0 105 for active nucleases (b) using the Wilcoxon
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39% (33/84) of the ZFNs that we tested (Supplementary
Table S1); we refer to these ZFNs as active. Because our
false-positive rate is 0.01%, ZFNs with somatic indel rates
<0.27% might be useful for generating germ line muta-
tions. For all mutations analysed, the number of mutant
embryos produced by each founder was <50%, indicating
that mutations were present in a subset of founder germ
cells (Supplementary Table S2a). Germ line indels ranged
in size from a 5-bp insertion to a 61-bp deletion (Figure 3).
ZFNs induced similar somatic and germ line indel sizes
regardless of mutation rate (Figure 3 and Supplementary
Figure S2a).
Most TALENs induce somatic mutations in vivo
TALEN technology has recently been applied to zebraﬁsh
(9,11–15). We sought to comprehensively assess the use of
TALENs for zebraﬁsh mutagenesis and compare them to
ZFNs. We used the REAL method (9) to generate 34
TALEN pairs that target 18 genes. Twenty-one (62%) of
the TALENs induced somatic indels at rates >10%, 29
(85%) at rates >1% and all at rates >0.1% (Figure 1c,
Supplementary Figure S1 and Supplementary Table S3).
33/34 (97%) induced somatic indels at rates >0.27%, and
should therefore generate germ line mutations at reason-
able frequencies. The single TALEN pair below this
threshold had an indel rate of 0.16%, which is still
above the false-positive rate of 0.01%. We conclude that
most, if not all, TALENs can induce somatic mutations,
and in this respect TALENs are superior to CoDA ZFNs.
A potential caveat to this conclusion is that we compared
ZFNs containing FokI EL/KK heterodimers with
TALENs containing FokI homodimers. However, this
difference is unlikely to underlie the higher mutagenicity
observed for TALENs, as TALENs containing FokI
heterodimers exhibit similar or higher mutation rates
than those containing homodimers (13), and the EL/KK
heterodimers used in our study and the ELD/KKR FokI
heterodimers primarily used by Cade et al. (13) induce
mutations at similar rates in zebraﬁsh (11). Nevertheless,
ELD/KKR heterodimers have been shown to be more
active than EL/KK heterodimers in some contexts (26),
and they might partially account for the difference in ZFN
and TALEN mutation rates in our study.
Somatic and germ line mutation rates are similarly
correlated for ZFNs and TALENs
We isolated germ line mutations using several TALEN
pairs and observed a strong correlation between somatic
and germ line mutation rates (Figure 2, r2=0.87,
P=7.2 104 for eight TALEN pairs). Notably, the
slopes of the linear regression lines and correlation coefﬁ-
cients are similar for TALENs and ZFNs, indicating that
the relationship between somatic and germ line mutation
rates is similar for ZFNs and TALENs. TALEN-induced
germ line indels ranged in size from a 23-bp insertion to a
203-bp deletion (Supplementary Figure S3 and Supple-
mentary Table S2b). TALENs induced similar somatic
and germ line indel sizes regardless of mutation rate
(Supplementary Figures S2b and S3).
Mutagenic TALENs exhibit higher indel rates than
mutagenic CoDA ZFNs
Having found that TALENs are much more likely than
CoDA ZFNs to be active (i.e. somatic indel rate >0.27%),
we next compared their somatic mutagenicity. The
average somatic indel rates for the 84 ZFNs and 34
TALENs were 2% and 20%, respectively (Figure 1a and
Supplementary Figure S1). If we only compare active nu-
cleases, the indel rates were 5% and 21%, respectively
(Figure 1b). These differences are statistically signiﬁcant
(P=5.1 1012 for all nucleases, P=6.0 105 for
active nucleases) and result from a shift in the distribution
of indel rates for TALENs compared with ZFNs and
higher rates for the most mutagenic TALENs (Figure 1c
and Supplementary Figure S1). For 10/11 genes that were
targeted using both ZFNs and TALENs, at least one
TALEN pair was more active than a ZFN pair, in most
cases by a large margin (Figure 1d and Supplementary
Table S4). Therefore, not only are TALENs more likely
than CoDA ZFNs to be active, they also induce mutations
Figure 1. Continued
rank-sum test. (c) Distribution of somatic indel rates for ZFNs and TALENs. Most ZFNs induced somatic indels at frequencies <1%, whereas
most TALENs induced indels at signiﬁcantly higher rates. (d) Somatic indel rates for 11 genes that were targeted with one or two pairs of ZFNs
and TALENs. For 10/11 genes, a TALEN pair induced higher indel rates than a ZFN pair. Z and T indicate ZFN and TALEN data. See
Supplementary Table S4 for indel rate values. (e) Distribution of somatic indel sizes for ZFNs and TALENs. TALEN-induced indels were signiﬁ-
cantly larger than ZFN-induced indels, with P=2.2 1016 using the Wilcoxon rank-sum test. Median indel sizes were 4nt and 9nt for ZFNs and
TALENs, respectively. Data are based on 5 527 940 and 2 893 241 sequence reads containing indels induced by TALENs and ZFNs, respectively.
Figure 2. Relationship between rates of somatic and germ line muta-
tions. There is a signiﬁcant correlation between rates of somatic and
germ line indels for ZFNs (r2=0.92, P=1.8 104, n=8 ZFNs using
Pearson’s correlation) and TALENs (r2=0.87, P=7.2 104, n=8
TALENs using Pearson’s correlation). The linear regression lines are
shown. Three TALENs induced germ line mutations in 100% of
injected ﬁsh. Among these three TALENs, only the TALEN with the
lowest somatic mutation rate was used in the Pearson’s correlation
calculation and to generate the linear regression line to avoid a
ceiling effect.
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at higher rates. The distribution of indel sizes is also sig-
niﬁcantly different for ZFN- and TALEN-induced muta-
tions (P=2.2 1016), with median indel sizes of 4nt and
9nt, respectively (Figure 1e).
Published guidelines do not predict ZFN or TALEN
mutagenicity in vivo
Several guidelines have been proposed to select optimal
ZFN and TALEN target sites but have not been exten-
sively tested in an animal. We used our data set to evaluate
how well these guidelines predict success in generating
mutations in vivo. First, we used the conﬁdence score
provided by the ZiFiT Targeter for ZFNs that are
generated using the OPEN method (27). This score is
based on analysis of zinc ﬁngers that activate transcription
of a reporter gene in a bacterial assay, which is correlated
with ZFN activity (2,10,28–30). Conﬁdence scores range
from 0 to 9, with 9 indicating the greatest likelihood of
mutagenicity. We compared scores for the 58 CoDA ZFN
pairs that we tested that could have been generated using
the OPEN method, but found no correlation between con-
ﬁdence score and indel rate (Figure 4a and b, P=0.69 and
P=0.65 for average and lowest score of ZFN pairs).
Second, it has been suggested that ZFNs are more likely
to be mutagenic if most or all nucleotide triplets in the
target sequence start with a guanine (3,4,31–36). We found
no correlation between mutation rate and target sites con-
taining four, ﬁve or six Gxx triplets (Figure 4c, P=0.30).
ZFN targets containing only four Gxx triplets might have
lower mutation rates, but our data set contains few of
these cases, and the difference that we observed is not
statistically signiﬁcant (Figure 4c). However, we did
observe a signiﬁcant negative correlation between the tar-
get sequence spacer length and mutagenicity (Figure 4d,
P=0.005). ZFN targets with a 7-bp spacer had much
lower mutation rates than those with 5- or 6-bp spacers.
We also evaluated guidelines proposed for designing
mutagenic TALENs. First, Cermak et al. (37) proposed
guidelines based on TAL effectors found in nature. In
addition to the well-established requirement that
TALEN binding sites should be preceded by a T
(Guideline 1) (37–39), which we followed for all
TALENs tested, they suggest that TALEN binding sites
should not have a T at position 1 (guideline 2) or an A at
position 2 (guideline 3) and should have a T at the last
position (guideline 4). They also suggest that TALEN
targets should have a nucleotide composition within
2 standard deviations of the average nucleotide compos-
ition of natural TALE targets (guideline 5). We failed to
detect correlations between TALEN mutagenicity and any
of these guidelines (Figure 4e–i and Supplementary Table
S5, P> 0.16 for all guidelines). Second, Streubel et al. (40)
generated artiﬁcial TALE arrays and tested their ability to
activate a reporter gene in plant cells. Based on their
results, they proposed that TALENs should contain at
least three to four repeats that bind C or G, whereas
stretches of repeats that interact with A or T should be
avoided, especially at the ends of target sites. We found no
correlation between indel rate and target G+C content
(Figure 4j, r2=0.07, P=0.12), although none of our
targets contained fewer than four G+C nucleotides. We
also did not observe a relationship between indel rates and
A/T repeats. Two TALEN target sites contained stretches
of six or seven A/T nucleotides, yet the TALENs targeting
these sites exhibited high-somatic mutation rates
(Supplementary Table S5). We note, however, that the
guidelines suggested by Streubel et al. are based on mono-
meric TALE proteins and may have less impact in the
context of TALEN dimers. Finally, we found that
diverse sequences can serve as nuclease targets
(Supplementary Figure S4), similar to observations in
human cells (41). We conclude that these guidelines have
Figure 3. Sequences of ZFN-induced germ line mutations. ZFN target
sequences and spacer sequence are highlighted in yellow and grey, re-
spectively. Deletions are indicated by red dashes and insertions are
highlighted in blue. Only mutations that were analysed using Sanger
sequencing are shown.
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little or no predictive power for TALEN mutagenicity in
zebraﬁsh.
TALEN mutagenicity is negatively correlated with the
number of CpG repeats in the target site
It has been shown that binding of TALE domains to their
targets is inhibited by 5-methylated cytosine (5mC) and
that demethylation of CpG repeats can improve TALE
activity in human and rodent cells (42,43). Consistent
with these reports, we observed a signiﬁcant negative cor-
relation between TALEN-induced somatic mutation rates
and the number of CpG repeats in target sites (Figure 5b
and Supplementary Table S6, r2=0.29, P=0.001).
TALEN targets containing zero or one CpG repeat ex-
hibited signiﬁcantly higher mutation rates than those con-
taining two or three CpG repeats (Figure 5b and
Supplementary Table S6). In support of this observation,
we found that three smaller zebraﬁsh studies that used the
same TALEN architecture as our study (9,11,13) showed a
similar effect (Supplementary Table S7). In particular, in
one study that targeted 10 zebraﬁsh genomic sites, the
three targets containing no CpG repeats had the highest
mutation rates, whereas the two targets containing
ﬁve CpG repeats were not mutagenic [Supplementary
Table S7 (13)]. We also analysed data from a large-scale
study of TALEN mutagenicity in human cells (41) but
found no correlation between mutation rates and the
number of CpG repeats in the target (Supplementary
Figure S5b and Supplementary Table S8, r2=0.01,
P=0.25), although targets with no CpG repeats had
higher average and median mutation rates than those con-
taining 1—4 CpGs. The basis for the discrepancy between
zebraﬁsh and human cells is unknown, but may result
from different CpG methylation patterns. In contrast to
TALENs, we did not observe a signiﬁcant correlation
between ZFN mutagenicity and the number of CpG
repeats in target sites (Figure 5a, Supplementary Figure
S5a and Supplementary Table S9, r2=0.03, P=0.09).
We conclude that, at least for zebraﬁsh studies, TALEN
target sites should contain no more than one CpG repeat.
DISCUSSION
ZFNs and TALENs have been used to generate somatic
and germ line mutations in zebraﬁsh (3,5–13,15) and rela-
tively small-scale studies have suggested that TALENs
may be superior mutagens (9,11–15). However, large-scale
comparisons of ZFN- and TALEN-induced mutations
have not been reported in any animal. Here, we describe
Figure 4. ZFN and TALEN targeting guidelines do not predict mutagenicity in zebraﬁsh embryos. There is no correlation between somatic indel
rate and the average (a) or lowest (b) OPEN score for each ZFN pair [r2=0.003, P=0.69 for (a) and r2=0.004, P=0.65 for (b) using Spearman’s
rank correlation]. Data for 58 ZFN pairs, for which ZiFiT OPEN scores are available, are shown. (c) There is no correlation between somatic indel
rate and the presence of four, ﬁve or six Gxx triplets in the ZFN target sequence (r2=0.01, P=0.30 using Spearman’s rank correlation). ZFN
targets containing four Gxx triplets may have lower mutation rates but do not reach a signiﬁcant threshold. (d) There is a correlation between
mutation rate and ZFN spacer length (r2=0.09, P=0.005 using Spearman’s rank correlation). ZFN targets containing 7-bp spacers have lower
mutation rates than those containing 5- or 6-bp spacers. There is no signiﬁcant difference in mutation rates for ZFN targets containing 5- or 6-bp
spacers (P=0.42 using the Wilcoxon rank-sum test). For (a–d), n indicates number of ZFN pairs. Panels (e–i) show somatic indel rates for each
TALEN pair for which neither, one or both target half-sites violate one of four design guidelines: (e) no T at position 1, (f) no A at position 2, (g) T
at last position and (h) nucleotide composition within 2 standard deviations of natural TALE targets (A=0 to 63%, C=11 to 63%, G=0 to 25%,
T=2 to 42%) (37). Panel (i) shows the total number of guideline violations for each target site (maximum number of violations=8). There is no
correlation between somatic mutation rate and violation of any of these guidelines, as determined using Spearman’s rank correlation (see r2 and P-
values on graphs e–i). (j) There is no correlation between TALEN-induced mutation rate and target sequence G+C content (r2=0.07, P=0.12
using Pearson’s correlation). The linear regression line is shown. Analysis in (e–j) was performed using 34 TALEN pairs.
Nucleic Acids Research, 2013, Vol. 41, No. 4 2775
 at California Institute of Technology on M
ay 30, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
a large-scale, deep sequencing-based comparison of ZFN
and TALEN mutagenicity in zebraﬁsh that provides
several insights.
First, as has been suggested by other studies (9,11–13),
we found that TALENs are signiﬁcantly more likely to be
mutagenic than ZFNs generated using CoDA. Eighty-ﬁve
percent of the 34 TALEN pairs that we tested induced
somatic indels at rates >1%, compared with only 25%
of the 84 ZFNs that we tested. Furthermore, all
TALENs induced mutations at rates signiﬁcantly greater
than our false-positive rate of 0.01%. We also found that
TALENs generated signiﬁcantly more mutations than
ZFNs. The average somatic mutation rates were 20%
and 2% for TALENs and ZFNs, respectively, indicating
that TALENs are on average 10-fold more mutagenic
than ZFNs. Second, by using deep sequencing to screen
for somatic mutations, we found that germ line mutants
can readily be isolated using ZFNs whose somatic
mutation rates are at least as low as 0.27%, which is
well below the standard cut-off of 1%, in accordance
with observations using a different ZFN methodology
(5). If we use a somatic indel rate of 0.27% as a threshold
to deﬁne nucleases that can generate germ line mutants at
reasonable frequencies, 97% of the TALENs and 39% of
the ZFNs that we tested are active in zebraﬁsh, with
average mutation rates of 21% and 5%, respectively.
This analysis also revealed that 89% of ZFNs induced
somatic indels at rates above our false-positive rate of
0.01%, suggesting that most ZFNs generated using
CoDA are mutagenic, although it may be difﬁcult to
isolate germ line mutations using ZFNs that have
somatic indel rates <0.27%. Third, we used our relatively
large data set to test whether several guidelines that have
been proposed to select optimal TALEN and ZFN target
sites are useful predictors of mutagenicity in vivo
(27,37,40). Our results indicate that none of these guide-
lines have strong predictive power in zebraﬁsh, and we
conclude that they should not be a factor in choosing
ZFN and TALEN target sites.
Although published guidelines did not predict ZFN or
TALEN mutagenicity in vivo, we did ﬁnd that TALEN
mutagenicity is negatively correlated with the number of
CpG repeats in the target sequence. TALEN targets con-
taining zero or one CpG repeat exhibited signiﬁcantly
higher mutation rates than those containing two or three
CpG repeats. Although not noted in their analysis, three
published zebraﬁsh studies that used the same TALEN
architecture as our study showed a similar effect (Supple-
mentary Table S7) (9,11,13). These results suggest that
target CpG methylation may inhibit TALEN
mutagenicity. We note that two TALENs with two or
three CpG repeats exhibited high mutation rates in our
study (Supplementary Table S6), but it is possible that
these sites are not methylated in vivo. Consistent with
these observations, the presence of 5mC in target DNA
can inhibit TALE activity, and demethylation can
improve TALE activity, in human and rodent cells
(42,43). It has been noted (42) that CpG methylation
may be associated with some of the non-mutagenic
TALENs described in a large-scale analysis of TALENs
in human cells (41), although we found no signiﬁcant cor-
relation between mutagenicity and the number of target
site CpGs in the overall data set (Supplementary Table
S8). The cause of the discrepancy between the zebraﬁsh
and human cell culture results is unclear, but may result
from different CpG methylation patterns in the human
cell line that was used compared with developing zebraﬁsh
embryos. It has been shown that use of the TALE repeat
N* rather than HD at 5mC residues can increase TALEN
activity, likely because of reduced steric hindrance of N*
compared with HD with the 5mC methyl moiety (42).
Taken together, these observations suggest that CpG
methylation could be a signiﬁcant factor in the low
mutagenicity of some TALENS, and that targeting CpG
residues using N* rather than HD could signiﬁcantly
improve mutagenicity at these targets. Alternatively, we
suggest that TALEN targets should not contain more
than one CpG repeat, at least for zebraﬁsh studies. In
contrast to TALENs, we did not observe a signiﬁcant cor-
relation between ZFN mutagenicity and the number of
target site CpG repeats (Supplementary Table S9).
Studies using plasmid-based and artiﬁcial genomic re-
porters in human cell lines and Xenopus oocytes found
that ZFNs whose targets contain 5- or 7-bp spacers were
less mutagenic than those containing 6-bp spacers (44–46).
In contrast, we found that endogenous ZFN targets con-
taining 5- or 6-bp spacers exhibited similar mutation rates,
consistent with several studies using animal models
(5,8,11). We also found that ZFN targets containing
7-bp spacers were 4- to 5-fold less likely to be mutagenic
and had signiﬁcantly lower mutation rates than targets
containing 5- or 6-bp spacers, even though we used ZFN
Figure 5. Somatic mutation rate of TALENs but not ZFNs is nega-
tively correlated with the number of CpG repeats in the target site.
There is no signiﬁcant correlation between somatic mutation rate and
the number of CpG repeats in ZFN target sequences (a, r2=0.03,
P=0.09 using Spearman’s rank correlation), but there is a signiﬁcant
negative correlation for TALEN target sequences (b, r2=0.29,
P=0.001 using Spearman’s rank correlation). Data points represent
somatic indel rates for each of the 84 ZFN (a) and 34 TALEN (b)
target sites that we tested. The box within each plot indicates the
middle half of the data, and the line in each box indicates the
median. The lines extending from the box indicate the farthest data
point that is within 1.5 interquartile ranges from the ﬁrst and third
quartiles. Individual data points outside these lines are possible
outliers. N indicates number of target sites in a category.
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architectures that were shown to be optimal for 5-, 6- and
7-bp spacers in human cells (44), suggesting that targets
containing 7-bp spacers should be avoided.
Our results are consistent with the largest test of
TALEN mutagenicity to date, which targeted 96 human
genes in cell culture (41). In this study, 88% of TALENs
produced mutation rates of 2–56%, with an average of
22%. In comparison, 85% of the TALENs that we
tested produced mutation rates of 1–66%, with an
average of 20%. Similar to our observations, this study
failed to detect correlations between target selection guide-
lines (37) and mutation rates (41). These results indicate
that TALENs mutate endogenous genes at similar rates in
human cells and developing zebraﬁsh embryos.
Our results demonstrate that TALENs are highly effect-
ive in generating mutations in zebraﬁsh, and that essen-
tially all TALENs are capable of inducing mutations,
although mutation rates vary considerably. This variation
is likely not completely due to the number of CpG repeats
in target sequences, because targets containing the same
number of CpG repeats exhibit a wide range of mutation
rates (Supplementary Tables S6 and S7), although this
might result from different methylation patterns in vivo.
Further work is therefore needed to understand the
basis of this variability, which should be facilitated
by high-throughput methods for TALEN construction
(41,47,48).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–9 and Supplementary Figures
1–5.
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